IFR US ECM PRICINGS
Array Technologies (US, renewable energy equipment) ─ $300m 6y cvt priced at 2.875%, up 27.5% versus 2.5%-3% and 27.5%-32.5% marketing. JEFF, GS, JPM. Upsized from $250m. Repaid $150m term loan. Concurrently repurchased $100m principal of 1% CB due 2028 for $78.3m. Capped call to $12.74, a 100% premium.
Cidara Therapeutics (US, biotech) ─ $350.0m FO. 8m shares (Primary) at $44.00 versus $44.95 last sale and $44.95 at launch. JPM, MS, GUGG, CANT. Upsized from $250m.
Forte Biosciences (US, biotech) ─ $75m ABB. 6.3m shares (Primary) at $12.00 versus $12.00-$13.00 marketing and $14.17 last sale. TDC, EVER, GUGG, CHDN. Wall cross. Includes shares sold as pre-funded warrants.
LightWave Acquisition (US, SPAC) ─ $187.5m IPO. 18.75m units (Primary) at $10.00. Each unit comprises one share and one-half warrant. BTIG. Nasdaq “LWACU”. Upsized from 15m units on 6/9. Robert Bennett. Technology. 24 months. 100.25% in trust.
Oxley Bridge Acquisition (Cayman Islands, SPAC) ─ $220m IPO. 22m units (Primary) at $10.00. Each unit comprises one share and one-half warrant. CANT. Nasdaq “OBAU”. Oxley Bridge Capital. Asia ex-China. 24 months. 100% in trust.
QXO (US, logistical services) ─ $2bn ABB. 89.9m shares (Primary) at $22.25 versus $22.25-$23.25 marketing and $23.51 last sale. GS, MS, WF.